nView s1 Reaches its 50th Surgery, Gets Navigation Capability

The nView s1, nView medical’s breakthrough imaging system, reached its 50th surgery. Twelve surgeons across three leading pediatric hospitals have used nView’s insta-3D™ technology on procedures ranging from spinal deformity corrections, to discectomies, periacetabular osteotomies and extremity procedures. nView medical CEO, Cristian Atria, said, “To celebrate the 50th surgery milestone we gave the nView s1 […]

Read More

Launch of Xenter Therapeutics

Following the close of $12M in Series A funding, Xenter, Inc., the world’s first start-up Device-Data-Drug healthcare technologies company, announced the launch of the Xenter Therapeutics business unit. Xenter Therapeutics will lead the therapeutic drug element of Xenter’s mission and vision and is headed by President and Xenter board member David J. Bearss, PhD, a biotech […]

Read More

Blackrock Neurotech Closes $10M Financing Round To Advance Development Of Its World-Leading Brain-Computer Interface (BCI) Technology

Blackrock Neurotech, the world’s leading platform for brain-computer interface (BCI) technology and manufacturing, has closed a $10 million financing round, led by Christian Angermayer’s re.Mind Capital with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact’s University Venture Fund II. The funding will further expand programs on the Blackrock platform, including clinical studies […]

Read More

ARUP Celebrates Opening of a New State-of-the-Art Laboratory Facility in Salt Lake City

Founded in 1984, ARUP Laboratories, one of the nation’s largest reference laboratories, on Tuesday held a ribbon cutting ceremony to officially open its new four-story, 220,000-square-foot laboratory facility located in University of Utah Research Park. The newly constructed facility is the crown jewel of eight properties ARUP now owns and operates as Research Park’s largest […]

Read More

Renalytix Announces Leadership Additions for Expanding KidneyIntelX Deployment

RenalytixAI has announced a series of key hires to drive its commercialization strategy in the U.S. market in light of the recently announced Federal Government General Service Administration payment contract and additional large healthcare system partnerships. The combined background and experience of the new leadership team is expected to drive adoption of the KidneyIntelX testing […]

Read More

Altitude Lab Launches Investor Coalition to Fund and Mentor Healthcare Startups in Utah

On June 8, Altitude Lab has announced the launch of its Investor Coalition, a partnered network of leading healthcare venture capitalists to fund, mentor, and provide resources for Altitude-incubated startups. Together, the investor coalition aims to collectively invest $50 million in Altitude’s startups over the next three years, specifically supporting diverse and underrepresented founders. In […]

Read More

Scientia Raises $50M to Develop Devices for Stroke, Cancer Treatment

Scientia announced it has raised $50M in growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm. The financing will be used to accelerate sales, marketing, and new product development in both its core neurovascular stroke market as well as adjacent markets in peripheral vascular and interventional oncology. “We are excited […]

Read More

Utah #1 For Best State Economic Outlook…Again

Utah has done it again! The 2021 “Rich States, Poor States” report recently released by the American Legislative Exchange Council (ALEC) ranks Utah as the state with the strongest economic outlook in the nation. Utah has held this first place designation for the past 14 years. View state-by-state data HERE. To determine its rankings, the […]

Read More

Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care

RenalytixA has announced results from a new utility study. The study confirms the importance of risk assessment testing in addressing treatment ambiguity in the early stages of diabetic kidney disease (DKD) and improving patient engagement and adherence – two major barriers to slowing or preventing DKD progression and preserving kidney health. In clinical studies, KidneyIntelX […]

Read More

Known Medicine Shows Its BioHive Pride

Known Medicine is creating the world’s largest purpose-built 3D cell culture data set to predict the best drug for every cancer patient and create the best drug for every cancer. From patient tumor samples the company generates hundreds of micro-tumors on our proprietary platform and treat them with an extensive panel of drugs or drug […]

Read More